Biological E. Limited Antitoxin Export Data — India (DGFT 2022–2026)

Name: Biological E. Limited Antitoxin Export Records India — #4 Exporter, 20 Shipments, $805.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Antitoxin

India Pharmaceutical Trade Intelligence

$13.3M45 Suppliers80 CountriesHS 30021220

ExportsIndia → FRANCE30.9%India → MOROCCO11.4%

ImportsCHINA → India$1.9M INDONESIA → India$984

#1 Supplier: VINS BIOPRODUCTS

Biological E. Limited — Antitoxin Exporter #4 | $1.1M Trade Value | TransData Nexus | TransData Nexus

Biological E. Limited — Antitoxin Exporter Profile

Indian Pharmaceutical Exporter · #4 for Antitoxin · $1.1M export value · DGFT Verified

Biological E. Limited is the #4 Indian exporter of Antitoxin with $1.1M in export value and 20 verified shipments. Biological E. Limited holds a 6.0% market share in Antitoxin exports across 10 countries. The company exports 5 pharmaceutical products worth $80.3M across 3 therapeutic categories.

Biological E. Limited — Antitoxin Export Profile: Buyers & Destinations

Biological E. Limited Antitoxin export treemap — buyers and destination countries | TransData Nexus

Where Does Biological E. Limited Export Antitoxin?

Country	Value	Shipments	Share
UNITED ARAB EMIRATES	$171.9K	4	33.7%
FRANCE	$154.1K	4	30.2%
NIGERIA	$100.0K	4	19.6%
MAURITANIA	$50.0K	1	9.8%
MADAGASCAR

Who Are the Top Buyers of Antitoxin from Biological E. Limited?

Buyer	Country	Value	Orders
WORLD HEALTH ORGANIZATION	UNITED ARAB EMIRATES	$171.9K	4
MSF LOG-BDX SITE MERIGNAC,	FRANCE	$127.8K	3
NCDC NIGERIA CENTRE FOR DISEASE	NIGERIA	$50.0K	1
NCDC (NIGERIA CENTRE FOR DISEASE	NIGERIA	$50.0K	1
CENTRALE D ACHAT DES MEDICAMENTS	MAURITANIA	$50.0K	1
MSF LOG-BDX SITE MERIGNAC	FRANCE	$26.2K	1
SALAMA	MADAGASCAR	$12.6K	1
GITTOES PHARMACEUTICALS LTD.,	UGANDA	$5.6K	1
WEHEHLIYE PHARMACEUTICALS IMPORT CO	SOMALIA	$4.5K	1
AFRICA HEALTH CARE PHARMA	GUINEA	$4.2K	1

Biological E. Limited supplies Antitoxin to 18 buyers globally. The largest buyer is WORLD HEALTH ORGANIZATION (UNITED ARAB EMIRATES), followed by MSF LOG-BDX SITE MERIGNAC, (FRANCE) and NCDC NIGERIA CENTRE FOR DISEASE (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Antitoxin Formulations Does Biological E. Limited Export?

Product Description / Formulation	Value	Shipments
DIPHTHERIA ANTITOXIN, 10,000 I.U, LYOPHILISED/LIQUID, 10 ML, VIAL	$121.9K	3
DIPHTHERIA ANTITOXIN 1000/IUML, 10ML VIALS	$100.0K	2
DIPHTHERIA ANTITOXIN 10 000 I U LYOPHILISED LIQUID 10 ML VIAL	$50.0K	1
DIPHTHERIA ANTITOXIN 10.000 I.U. LYOPHILISED/ LIQUID 10 ML VIAL	$50.0K	1
DIPHTHERIA ANTITOXIN, 10,000 I.U, LYOPHILISED/LIQUID, 10 ML, VIALVLS	$50.0K	1
DIPHTHERIA ANTITOXIN I P 1000 IUML 10ML VIALS DIPHTHERIA ANTITOXIN 10 000 I U 10ML VIAL	$50.0K	1
DIPHTHERIA ANTITOXIN I.P. 1000/IUML, 10ML VIALS	$27.8K	1
DIPHTHEREIA ANTITOXIN I.P.1000/IUML10 ML VIALS	$26.2K	1
TENTANUS ANTITOXIN BP 1500UI ML 1ML	$12.6K	1
TETANUS ANTITOXIN BP (1500 IU/ML)-1ML AMPOULE (BEATS)	$5.6K	1

Biological E. Limited exports 21 distinct Antitoxin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DIPHTHERIA ANTITOXIN, 10,000 I.U, LYOPHILISED/LIQUID, 10 ML, with 3 shipments worth $121.9K.

How Does Biological E. Limited Compare to Nearest Antitoxin Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	PREMIUM SERUMS AND VACCINES PRIVATE LIMITED	$1.4M	71	19	$19.0K
3	SERUM INSTITUTE OF INDIA PRIVATE LIMITED	$999.9K	62	23	$16.1K
4	BIOLOGICAL E. LIMITED ★	$805.0K	20	10	$40.2K
5	VINS BIOPRODUCTS LTD	$373.1K	19	7	$19.6K
6	BIOLOGICAL E LIMITED ★	$293.2K	6	4	$48.9K

Biological E. Limited ranks #4 among 45 Indian Antitoxin exporters. Average shipment value of $40.2K compared to the market average of $292.9K. The closest competitors by value are PREMIUM SERUMS AND VACCINES PRIVATE LIMITED and SERUM INSTITUTE OF INDIA PRIVATE LIMITED.

Which Indian Ports Ship Antitoxin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	125	23.9%
HYDERABAD ACC (INHYD4)	99	18.9%
HYDERABAD AIR	87	16.6%
SAHAR AIR	74	14.1%
Bombay Air	33	6.3%
Hyderabad Air	25	4.8%
HYDERABAD ICD	12	2.3%
DELHI AIR	12	2.3%

Geopolitical & Trade Policy Impact on Biological E. Limited's Antitoxin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like BE. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight charges and potential losses estimated between ₹2,500 crore and ₹5,000 crore for the Indian pharma industry in March 2026. (fortuneindia.com) These disruptions can elongate lead times and elevate cold-chain failure risks, particularly for temperature-sensitive products like vaccines. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have prompted the U.S. to seek alternative suppliers, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the U.S. in August 2025 posed challenges, with Indian exporters facing increased costs and competitive disadvantages. (apnews.com) The subsequent withdrawal of tariffs on generic drugs in October 2025 provided some relief, yet the episode underscores the volatility of trade policies and the need for exporters to remain agile. (medboundtimes.com)

In the European Union, compliance with the Falsified Medicines Directive requires stringent serialization and traceability measures. For companies like BE, ensuring adherence to these regulations is crucial to maintain market access and uphold their reputation for quality.

Biological E. Limited — Regulatory Compliance & Quality Standards

Regulatory compliance remains a cornerstone for Indian pharmaceutical exporters. The U.S. FDA has intensified inspections, with over 200 conducted in 2023 and plans to increase this number in 2024. (fact.net.in) Instances of quality issues and FDA warnings have previously affected the reputation of Indian pharma exports. (svhealthcare.in) For BE, maintaining compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP) is imperative to sustain and expand its export footprint.

The company's recent WHO pre-qualification for nOPV2 reflects its commitment to quality and regulatory excellence. However, the broader industry faces challenges related to counterfeit drugs and quality concerns, which can impact India's reputation as a reliable supplier. (fact.net.in) Proactive measures, including robust quality assurance systems and transparent governance, are essential for BE to navigate this evolving landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Antitoxin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Biological E. Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 26 individual customs records matching Biological E. Limited exporting Antitoxin, covering 21 formulations to 12 countries via 18 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 80+ countries, 238+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Antitoxin

Antitoxin

Biological E. Limited — Antitoxin Exporter Profile

Biological E. Limited — Antitoxin Export Profile: Buyers & Destinations

Where Does Biological E. Limited Export Antitoxin?

Who Are the Top Buyers of Antitoxin from Biological E. Limited?

What Is India's Total Antitoxin Export Value and How Much Does Biological E. Limited Contribute?

What Is the Average Shipment Value for Biological E. Limited's Antitoxin Exports?

How Does Biological E. Limited Compare to Other Indian Antitoxin Exporters?

What Antitoxin Formulations Does Biological E. Limited Export?

Regulatory Requirements: Exporting Antitoxin to Key Markets

Nigeria — NAFDAC

How Does Biological E. Limited Compare to Nearest Antitoxin Exporters?

Which Indian Ports Ship Antitoxin Exports?

What Other Other Products Does Biological E. Limited Export?

Geopolitical & Trade Policy Impact on Biological E. Limited's Antitoxin Exports

Biological E. Limited — Regulatory Compliance & Quality Standards

About Biological E. Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Antitoxin Export Data from Biological E. Limited

Antitoxin Stats

Company Overview

Top Products by Biological E. Limited

Related Analysis

Need Detailed Export Data?

Data Source